Showing 8341-8350 of 9548 results for "".
- Precision Dermatology Names New CEOhttps://practicaldermatology.com/news/20130924-precision_dermatology_names_new_ceo/2459455/Robert J. Moccia has been appointed to the position of Chief Executive Officer at Precision Dermatology Inc. Mr. Moccia has led the introduction of a number of new strategies for growth since joining the company in January of this year. Mr. Moccia has 30 years of experience in dermatology, having mo
- ResurFX for M22 Platform from Lumenis Receives FDA Clearancehttps://practicaldermatology.com/news/20130917-resurfx_for_m22_platform_from_lumenis_receives_fda_clearance/2459459/The FDA recently granted 510(k) clearance for ResurFX, a new fractional non-ablative laser module from Lumenis. ResurFX is the latest application module for the company's M22 platform, expanding its capabilities to perform true fractional non-ablative skin resurfacing.
- Do Physicians Mention Sunscreen Use Often Enough at Patient Visits?https://practicaldermatology.com/news/20130905-do_physicians_mention_sunscreen_use_often_enough_at_patient_visits/2459468/
- Novan Awarded Contract by BARDA to Develop a Medical Countermeasure for Thermal Burnshttps://practicaldermatology.com/news/20130829-novan_awarded_contract_by_barda_to_develop_a_medical_countermeasure_for_thermal_burns/2459472/
- Speech Recognition Software Gets Boosthttps://practicaldermatology.com/news/20130828-speech_recognition_software_gets_boost/2459473/Spellex has released Spellex Dictation, a dictionary enhancement for Dragon NaturallySpeaking and other popular speech recognition software. Spellex says the dictation program allows users to dictate and correctly spell healthcare, legal, and BioScientific and engineering words and phrases.
- FDA Approves Valchlor Gel for the Treatment of Stage IA and IB Mycosis Fungoides-Type CTCLhttps://practicaldermatology.com/news/20130826-fda_approves_valchlor_gel_for_the_treatment_of_stage_ia_and_ib_mycosis_fungoides-type_ctcl/2459475/
- Psoriasis Foundation Urges CMS to Halt Proposed Cuts to Phototherapy Reimbursementhttps://practicaldermatology.com/news/20130815-psoriasis_foundation_urges_cms_to_halt_proposed_cuts_to_phototherapy_reimbursement/2459477/The National Psoriasis Foundation has stepped up efforts to halt the Centers for Medicare and Medicaid Services (CMS) plan to cut reimbursement rates to phototherapy in the proposed CY 2014 Medicare Physician Fee Schedule (PFS). According to the Foundation, if the proposed cuts pass, many physicians
- Acne-Specific Dermatology Platform Site Goes Livehttps://practicaldermatology.com/news/20130801-acne-specific_dermatology_platform_site_goes_live/2459485/
- Mentor, Medicis Unveiling Joint New Physician Loyalty Programhttps://practicaldermatology.com/news/20130717-mentor_medicis_unveiling_joint_new_physician_loyalty_program/2459494/Mentor Worldwide, LLC and Valeant's Medicis division have entered into a Collaboration Agreement to form a joint physician loyalty program called the M2VP P
- Leading Scientist Behind SkinCeuticals Dies At 76https://practicaldermatology.com/news/20130712-dr_sheldon_pinnell_the_founding_father_of_topical_antioxidants_leading_scientist_behind_skinceuticals_and_chief_emeritus_of_the_division_of_dermatolog/2459500/Dr. Sheldon Pinnell, an internationally eminent scientist, dermatologist, leading scientist behind L'Oreal-owned SkinCeuticals, and J. Lamar Callaway Professor Emeritus of Dermatology and Chief Emeritus of the Division of Dermatology at Duke University, passed away peacefully in Durham, North Caroli